| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | helicase activity | 1.03e-05 | 158 | 132 | 8 | GO:0004386 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.17e-05 | 127 | 132 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 2.53e-05 | 130 | 132 | 7 | GO:0005200 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | WAPL EP400 ATRX CENPE DDX10 SMARCA1 NAV2 DDX23 HFM1 ABCC12 DYNC1H1 SMC1B VCP HELLS | 5.68e-05 | 614 | 132 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | insulin-like growth factor I binding | 7.69e-05 | 13 | 132 | 3 | GO:0031994 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | WAPL EP400 ATRX KHNYN DDX10 NUDT12 TRNT1 SMARCA1 NAV2 DDX23 HFM1 RNASEH1 TARBP1 HELLS | 9.59e-05 | 645 | 132 | 14 | GO:0140640 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.02e-04 | 37 | 132 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity | 1.30e-04 | 3 | 132 | 2 | GO:0048101 | |
| GeneOntologyMolecularFunction | calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity | 1.30e-04 | 3 | 132 | 2 | GO:0004117 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.48e-04 | 16 | 132 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 2.53e-04 | 19 | 132 | 3 | GO:0005520 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 3.44e-04 | 21 | 132 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-AMP phosphodiesterase activity | 3.97e-04 | 22 | 132 | 3 | GO:0004115 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-GMP phosphodiesterase activity | 5.16e-04 | 24 | 132 | 3 | GO:0047555 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-nucleotide phosphodiesterase activity | 5.84e-04 | 25 | 132 | 3 | GO:0004114 | |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 7.35e-04 | 27 | 132 | 3 | GO:0004112 | |
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity | 1.18e-03 | 8 | 132 | 2 | GO:0004571 | |
| GeneOntologyCellularComponent | spectrin | 1.19e-09 | 9 | 133 | 5 | GO:0008091 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 2.87e-05 | 93 | 133 | 6 | GO:0030864 | |
| GeneOntologyCellularComponent | cuticular plate | 6.87e-05 | 13 | 133 | 3 | GO:0032437 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 1.78e-04 | 129 | 133 | 6 | GO:0030863 | |
| Domain | Spectrin | 4.96e-07 | 23 | 132 | 5 | PF00435 | |
| Domain | Spectrin_repeat | 1.69e-06 | 29 | 132 | 5 | IPR002017 | |
| Domain | SPEC | 2.82e-06 | 32 | 132 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.82e-06 | 32 | 132 | 5 | IPR018159 | |
| Domain | Helicase_C | 1.09e-05 | 107 | 132 | 7 | PF00271 | |
| Domain | HELICc | 1.09e-05 | 107 | 132 | 7 | SM00490 | |
| Domain | Helicase_C | 1.16e-05 | 108 | 132 | 7 | IPR001650 | |
| Domain | HELICASE_CTER | 1.23e-05 | 109 | 132 | 7 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.23e-05 | 109 | 132 | 7 | PS51192 | |
| Domain | DEXDc | 1.23e-05 | 109 | 132 | 7 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.31e-05 | 110 | 132 | 7 | IPR014001 | |
| Domain | SNF2_N | 7.35e-05 | 32 | 132 | 4 | IPR000330 | |
| Domain | SNF2_N | 7.35e-05 | 32 | 132 | 4 | PF00176 | |
| Domain | PDEase_N | 1.48e-04 | 3 | 132 | 2 | IPR013706 | |
| Domain | PDEase_I_N | 1.48e-04 | 3 | 132 | 2 | PF08499 | |
| Domain | Sec63 | 2.95e-04 | 4 | 132 | 2 | PF02889 | |
| Domain | Sec63 | 2.95e-04 | 4 | 132 | 2 | SM00973 | |
| Domain | Sec63-dom | 2.95e-04 | 4 | 132 | 2 | IPR004179 | |
| Domain | Spectrin_bsu | 2.95e-04 | 4 | 132 | 2 | IPR016343 | |
| Domain | PDEase | 3.08e-04 | 19 | 132 | 3 | IPR023088 | |
| Domain | - | 3.86e-04 | 248 | 132 | 8 | 1.25.40.20 | |
| Domain | PDEase_I | 4.18e-04 | 21 | 132 | 3 | PF00233 | |
| Domain | PDEASE_I | 4.18e-04 | 21 | 132 | 3 | PS00126 | |
| Domain | PDEase_CS | 4.18e-04 | 21 | 132 | 3 | IPR023174 | |
| Domain | SANT | 4.27e-04 | 50 | 132 | 4 | SM00717 | |
| Domain | Ankyrin_rpt-contain_dom | 4.53e-04 | 254 | 132 | 8 | IPR020683 | |
| Domain | - | 4.82e-04 | 22 | 132 | 3 | 1.10.1300.10 | |
| Domain | SANT/Myb | 4.96e-04 | 52 | 132 | 4 | IPR001005 | |
| Domain | PDEase_catalytic_dom | 5.51e-04 | 23 | 132 | 3 | IPR002073 | |
| Domain | Ankyrin_rpt | 5.55e-04 | 262 | 132 | 8 | IPR002110 | |
| Domain | HD/PDEase_dom | 6.26e-04 | 24 | 132 | 3 | IPR003607 | |
| Domain | HDc | 6.26e-04 | 24 | 132 | 3 | SM00471 | |
| Domain | EFhand_Ca_insen | 7.30e-04 | 6 | 132 | 2 | PF08726 | |
| Domain | EF-hand_Ca_insen | 7.30e-04 | 6 | 132 | 2 | IPR014837 | |
| Domain | SANT_dom | 7.97e-04 | 26 | 132 | 3 | IPR017884 | |
| Domain | - | EP400 ATRX LRRK2 DDX10 SMARCA1 NAV2 DDX23 HFM1 ABCC12 HYDIN DYNC1H1 SMC1B VCP HELLS | 8.18e-04 | 746 | 132 | 14 | 3.40.50.300 |
| Domain | EGF_extracell | 8.56e-04 | 60 | 132 | 4 | IPR013111 | |
| Domain | EGF_2 | 8.56e-04 | 60 | 132 | 4 | PF07974 | |
| Domain | SH3 | 8.73e-04 | 216 | 132 | 7 | SM00326 | |
| Domain | SH3 | 8.73e-04 | 216 | 132 | 7 | PS50002 | |
| Domain | P-loop_NTPase | EP400 ATRX CENPE LRRK2 DDX10 SMARCA1 NAV2 DDX23 HFM1 ABCC12 HYDIN DYNC1H1 SMC1B VCP HELLS | 9.69e-04 | 848 | 132 | 15 | IPR027417 |
| Domain | SH3_domain | 9.71e-04 | 220 | 132 | 7 | IPR001452 | |
| Domain | SANT | 9.93e-04 | 28 | 132 | 3 | PS51293 | |
| Domain | Glyco_hydro_47 | 1.02e-03 | 7 | 132 | 2 | PF01532 | |
| Domain | - | 1.02e-03 | 7 | 132 | 2 | 1.50.10.50 | |
| Domain | SH3_1 | 1.10e-03 | 164 | 132 | 6 | PF00018 | |
| Domain | Ank | 1.19e-03 | 228 | 132 | 7 | PF00023 | |
| Domain | VWA_3 | 1.35e-03 | 8 | 132 | 2 | PF13768 | |
| Domain | Glyco_hydro_47 | 1.35e-03 | 8 | 132 | 2 | IPR001382 | |
| Domain | Prefoldin | 1.69e-03 | 72 | 132 | 4 | IPR009053 | |
| Domain | PH_dom-spectrin-type | 1.73e-03 | 9 | 132 | 2 | IPR001605 | |
| Domain | EGF | 2.02e-03 | 126 | 132 | 5 | PF00008 | |
| Domain | ANK | 2.07e-03 | 251 | 132 | 7 | SM00248 | |
| Domain | ANK_REPEAT | 2.16e-03 | 253 | 132 | 7 | PS50088 | |
| Domain | ANK_REP_REGION | 2.21e-03 | 254 | 132 | 7 | PS50297 | |
| Domain | MYB_LIKE | 2.43e-03 | 38 | 132 | 3 | PS50090 | |
| Domain | Keratin_I | 3.70e-03 | 44 | 132 | 3 | IPR002957 | |
| Domain | TIL_dom | 4.27e-03 | 14 | 132 | 2 | IPR002919 | |
| Domain | Ldl_recept_b | 4.27e-03 | 14 | 132 | 2 | PF00058 | |
| Domain | LDLRB | 4.27e-03 | 14 | 132 | 2 | PS51120 | |
| Domain | Ank_2 | 4.27e-03 | 215 | 132 | 6 | PF12796 | |
| Domain | LY | 4.90e-03 | 15 | 132 | 2 | SM00135 | |
| Domain | Spectrin_alpha_SH3 | 4.90e-03 | 15 | 132 | 2 | IPR013315 | |
| Domain | LDLR_classB_rpt | 4.90e-03 | 15 | 132 | 2 | IPR000033 | |
| Domain | Growth_fac_rcpt_ | 5.04e-03 | 156 | 132 | 5 | IPR009030 | |
| Domain | Protein_kinase_ATP_BS | 5.56e-03 | 379 | 132 | 8 | IPR017441 | |
| Domain | GATA_ZN_FINGER_1 | 5.58e-03 | 16 | 132 | 2 | PS00344 | |
| Domain | GATA_ZN_FINGER_2 | 5.58e-03 | 16 | 132 | 2 | PS50114 | |
| Domain | PH | 5.79e-03 | 229 | 132 | 6 | PF00169 | |
| Domain | - | 6.80e-03 | 106 | 132 | 4 | 1.10.150.50 | |
| Domain | ZF_MATRIN | 7.04e-03 | 18 | 132 | 2 | PS50171 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 5.46e-07 | 10 | 103 | 4 | MM15112 | |
| Pathway | WP_G_PROTEIN_SIGNALING_PATHWAYS | 4.98e-05 | 90 | 103 | 6 | MM15882 | |
| Pathway | WP_G_PROTEIN_SIGNALING | 5.30e-05 | 91 | 103 | 6 | M39426 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 7.27e-05 | 31 | 103 | 4 | M877 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | MAN1A1 COG7 SPTA1 SPTAN1 SPTBN1 SPTBN4 EDEM3 B4GALNT2 DYNC1H1 VCP | 8.17e-05 | 307 | 103 | 10 | M894 |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.00e-04 | 102 | 103 | 6 | M27648 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.37e-04 | 68 | 103 | 5 | MM14968 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.52e-04 | 110 | 103 | 6 | MM15350 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.64e-04 | 38 | 103 | 4 | MM14969 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | 2.91e-04 | 293 | 103 | 9 | MM15120 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRT14 KRT15 KRT17 KALRN SPTA1 SPTAN1 SPTBN1 LIPN ITGB3 DSCAML1 SPTBN4 LYN | 2.93e-04 | 502 | 103 | 12 | MM14537 |
| Pubmed | CYLD WAPL ATRX KALRN SPTAN1 SPTBN1 SPOCK2 PSMD7 CBS DSCAML1 ZBED5 LDB2 KRIT1 SPTBN4 NAA25 MTA1 EIF4G1 LRP2 IFT122 METAP2 TARBP1 DYNC1H1 VCP USP47 | 1.19e-10 | 1285 | 133 | 24 | 35914814 | |
| Pubmed | UBTD2 KRT14 KRT15 KRT17 ATRX CENPF SPTA1 PPFIA1 SPTAN1 MATR3 SPTBN1 COQ6 ANKRD30B PSMD7 SPTBN4 TRNT1 EIF4G1 SMARCA1 NAV2 DDX23 CEP295 IFT122 | 3.03e-08 | 1442 | 133 | 22 | 35575683 | |
| Pubmed | Brain proteins interacting with the tetramerization region of non-erythroid alpha spectrin. | 6.61e-08 | 11 | 133 | 4 | 17607528 | |
| Pubmed | 1.30e-07 | 151 | 133 | 8 | 17043677 | ||
| Pubmed | CYLD WAPL TTLL3 ATRX PPFIA1 MATR3 SPTBN1 ZNF429 SPOCK2 ADCY3 AREL1 TRNT1 MTA1 LRP2 CEP295 ANKRD12 SEC63 QSOX2 | 1.82e-07 | 1084 | 133 | 18 | 11544199 | |
| Pubmed | 2.18e-07 | 4 | 133 | 3 | 21566095 | ||
| Pubmed | Remarkable homology among the internal repeats of erythroid and nonerythroid spectrin. | 2.18e-07 | 4 | 133 | 3 | 3862089 | |
| Pubmed | Spectrin alpha II and beta II isoforms interact with high affinity at the tetramerization site. | 2.18e-07 | 4 | 133 | 3 | 12820899 | |
| Pubmed | WDR36 CENPF SPTAN1 SPTBN1 ZC3H18 DDX10 NUP210 EIF4G1 DDX23 TNKS1BP1 DYNC1H1 VCP HERC5 USP47 | 2.32e-07 | 653 | 133 | 14 | 22586326 | |
| Pubmed | HIP1 WDR36 SPTAN1 MATR3 SPTBN1 WDR55 ZC3H18 EIF4G1 SMARCA1 DDX23 TNKS1BP1 RNASEH1 LYN VCP | 2.63e-07 | 660 | 133 | 14 | 32780723 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT14 KRT15 WDR36 KRT17 CENPF SPTAN1 MATR3 SPTBN1 ZC3H18 NDUFA9 DNAJC2 NUP210 EIF4G1 SMARCA1 TNKS1BP1 SEC63 LYN METAP2 DYNC1H1 | 3.39e-07 | 1257 | 133 | 19 | 36526897 |
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 21406181 | ||
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 6.00e-07 | 18 | 133 | 4 | 12119179 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | KRT14 EP400 KALRN SPTAN1 MATR3 SPTBN1 SPOCK2 ZC3H18 ZBED5 MAMDC2 ARID2 EIF4G1 DDX23 TNKS1BP1 SEC63 DYNC1H1 VCP | 8.80e-07 | 1082 | 133 | 17 | 38697112 |
| Pubmed | CYLD KALRN CENPE CENPF PPFIA1 SPTAN1 MATR3 SPTBN1 PEX5L LDB2 SPTBN4 AKAP9 EIF4G1 PRKCB TAF5 DYNC1H1 | 9.18e-07 | 963 | 133 | 16 | 28671696 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | WDR36 KRT17 ATRX MATR3 ZC3H18 DDX10 NAA25 SMARCA1 DDX23 TAF5 DYNC1H1 HELLS | 1.06e-06 | 533 | 133 | 12 | 30554943 |
| Pubmed | 1.89e-06 | 7 | 133 | 3 | 16818453 | ||
| Pubmed | CYLD EP400 ATRX SPTAN1 MATR3 SPTBN1 ETV6 GCM1 PSMD7 ZC3H18 DDX10 MTA1 ARID2 EIF4G1 SMARCA1 LRP2 TAF5 DYNC1H1 HELLS | 2.27e-06 | 1429 | 133 | 19 | 35140242 | |
| Pubmed | Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. | 2.43e-06 | 25 | 133 | 4 | 8493579 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 2.63e-06 | 101 | 133 | 6 | 23382219 | |
| Pubmed | 3.31e-06 | 163 | 133 | 7 | 16512683 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | WAPL CENPE CENPF PPFIA1 SPTBN1 PSMD7 ARID2 NAV2 DDX23 HYDIN HELLS | 3.58e-06 | 497 | 133 | 11 | 36774506 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | KRT14 WDR36 KRT17 MATR3 SPTBN1 ZC3H18 DDX10 MTA1 EIF4G1 SMARCA1 DDX23 HELLS | 3.91e-06 | 605 | 133 | 12 | 28977666 |
| Pubmed | CYLD UBR2 EP400 KHNYN SPOCK2 ADCY3 AKAP9 ANKRD12 DYNC1H1 ARAP2 | 4.06e-06 | 407 | 133 | 10 | 12693553 | |
| Pubmed | microRNA-184 Induces a Commitment Switch to Epidermal Differentiation. | 4.52e-06 | 9 | 133 | 3 | 29198823 | |
| Pubmed | AVEN WDR36 EP400 PPFIA1 SPTAN1 MATR3 SPTBN1 WDR55 DDX10 AKAP9 EIF4G1 SMARCA1 DDX23 SEC63 RNASEH1 METAP2 DYNC1H1 VCP | 5.13e-06 | 1371 | 133 | 18 | 36244648 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | UBR2 WAPL EP400 WDR55 LDB2 MTA1 EIF4G1 SMARCA1 RNASEH1 DYNC1H1 NOTCH1 HERC5 USP47 HELLS | 5.58e-06 | 857 | 133 | 14 | 25609649 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 5.70e-06 | 332 | 133 | 9 | 32786267 | |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 6.43e-06 | 10 | 133 | 3 | 22159418 | |
| Pubmed | 6.48e-06 | 118 | 133 | 6 | 30979931 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 7.06e-06 | 341 | 133 | 9 | 32971831 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 7.14e-06 | 120 | 133 | 6 | 31413325 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | KRT14 KRT15 KRT17 SPTAN1 MATR3 SPTBN1 ZC3H18 NDUFA9 CBS DNAJC2 EIF4G1 DDX23 TNKS1BP1 METAP2 TARBP1 DYNC1H1 VCP HELLS | 7.89e-06 | 1415 | 133 | 18 | 28515276 |
| Pubmed | 8.82e-06 | 11 | 133 | 3 | 16085486 | ||
| Pubmed | 9.06e-06 | 266 | 133 | 8 | 19380743 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | WAPL CENPE CENPF COG7 MATR3 INSR STK3 EDEM3 ARID2 EIF4G1 DDX23 TNKS1BP1 DYNC1H1 VCP USP47 ARAP1 | 9.27e-06 | 1155 | 133 | 16 | 20360068 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | KRT14 WDR36 KRT17 EP400 CENPF MATR3 INSR DDX10 NUP210 EIF4G1 DDX23 LYN DYNC1H1 VCP HELLS | 9.35e-06 | 1024 | 133 | 15 | 24711643 |
| Pubmed | 9.37e-06 | 191 | 133 | 7 | 33762435 | ||
| Pubmed | CYLD AVEN KRT14 WDR36 KRT17 EP400 PPFIA1 INSR LRRK2 PSMD7 DYNC1H1 ARAP2 HELLS | 9.54e-06 | 777 | 133 | 13 | 35844135 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | KRT14 KRT15 KRT17 MATR3 COQ6 PSMD7 ZC3H18 NDUFA9 DNAJC2 EIF4G1 SMARCA1 DYNC1H1 | 1.01e-05 | 665 | 133 | 12 | 30457570 |
| Pubmed | KRT15 SPTAN1 MATR3 SPTBN1 ITGB3 EIF4G1 TNKS1BP1 METAP2 DYNC1H1 | 1.09e-05 | 360 | 133 | 9 | 33111431 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | WAPL WDR36 EP400 MATR3 AASDHPPT PSMD7 NDUFA9 DDX10 TRNT1 EIF4G1 DDX23 PRKCB TAF5 SEC63 LYN METAP2 DYNC1H1 | 1.21e-05 | 1318 | 133 | 17 | 30463901 |
| Pubmed | WDR36 EP400 ATRX ZC3H18 MTA1 NUP210 SMARCA1 TNKS1BP1 HYDIN HELLS | 1.39e-05 | 469 | 133 | 10 | 27634302 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 21103378 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 24168496 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 7539810 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 29549916 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 8163551 | ||
| Pubmed | Identification of a mouse brain beta-spectrin cDNA and distribution of its mRNA in adult tissues. | 1.45e-05 | 2 | 133 | 2 | 1742606 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 2433272 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 31066149 | ||
| Pubmed | αII-spectrin regulates invadosome stability and extracellular matrix degradation. | 1.45e-05 | 2 | 133 | 2 | 25830635 | |
| Pubmed | Stage and cell-specific expression of calmodulin-dependent phosphodiesterases in mouse testis. | 1.45e-05 | 2 | 133 | 2 | 11369604 | |
| Pubmed | Spectrin-actin interaction is required for neurite extension in NB 2a/dl neuroblastoma cells. | 1.45e-05 | 2 | 133 | 2 | 8776664 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 2580298 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 29693772 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 21373883 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 6186381 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 36006534 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 26682927 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 20871598 | ||
| Pubmed | Screening diagnostic biomarkers of OSCC via an LCM-based proteomic approach. | 1.45e-05 | 2 | 133 | 2 | 30066921 | |
| Pubmed | Identification of a novel TEL-Lyn fusion gene in primary myelofibrosis. | 1.45e-05 | 2 | 133 | 2 | 19710703 | |
| Pubmed | CD8+ T cells regulate bone tumor burden independent of osteoclast resorption. | 1.45e-05 | 2 | 133 | 2 | 21602433 | |
| Pubmed | Notch1 regulates maturation of CD4+ and CD8+ thymocytes by modulating TCR signal strength. | 1.45e-05 | 2 | 133 | 2 | 11290335 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 17905835 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 7851898 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 8406479 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | WAPL WDR36 EP400 ATRX MATR3 AASDHPPT PSMD7 CBS DDX10 ARID2 TNKS1BP1 VCP HERC5 HELLS | 1.47e-05 | 934 | 133 | 14 | 33916271 |
| Pubmed | 1.52e-05 | 13 | 133 | 3 | 18796539 | ||
| Pubmed | CYLD WDR36 ATRX PPFIA1 SPTAN1 SPTBN1 PSMD7 NDUFA9 DNAJC2 DDX10 AKAP9 NUP210 DDX23 IFT122 SEC63 VCP HERC5 HELLS | 1.54e-05 | 1487 | 133 | 18 | 33957083 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | WAPL WDR36 EP400 SPTAN1 MATR3 SPTBN1 PSMD7 NDUFA9 ZBED5 DDX10 EIF4G1 SMARCA1 DDX23 PLCG2 METAP2 DYNC1H1 VCP | 1.69e-05 | 1353 | 133 | 17 | 29467282 |
| Pubmed | 1.84e-05 | 84 | 133 | 5 | 34159380 | ||
| Pubmed | Mice with a targeted mutation of patched2 are viable but develop alopecia and epidermal hyperplasia. | 1.93e-05 | 14 | 133 | 3 | 16914743 | |
| Pubmed | 1.93e-05 | 14 | 133 | 3 | 20572855 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.22e-05 | 394 | 133 | 9 | 27248496 | |
| Pubmed | 2.27e-05 | 147 | 133 | 6 | 16959763 | ||
| Pubmed | Tsukushi controls the hair cycle by regulating TGF-β1 signaling. | 2.41e-05 | 15 | 133 | 3 | 22995554 | |
| Pubmed | 2.41e-05 | 15 | 133 | 3 | 10087197 | ||
| Pubmed | Multiple roles of Notch signaling in the regulation of epidermal development. | 2.41e-05 | 15 | 133 | 3 | 18410734 | |
| Pubmed | Novel associations for hypothyroidism include known autoimmune risk loci. | 2.46e-05 | 44 | 133 | 4 | 22493691 | |
| Pubmed | CYLD WAPL EP400 PPFIA1 ZC3H18 EDEM3 MTA1 ARID2 SMARCA1 LRP2 CEP295 TAF5 QSOX2 VCP ARAP2 | 2.55e-05 | 1116 | 133 | 15 | 31753913 | |
| Pubmed | EP400 CENPF SPTAN1 SPTBN1 PSMD7 DDX10 MTA1 DDX23 DYNC1H1 VCP | 2.66e-05 | 506 | 133 | 10 | 30890647 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | PDE1A STAB2 SPTA1 SPTAN1 SPTBN1 NDUFA9 PEX5L PRKCB LYN DYNC1H1 VCP | 2.85e-05 | 621 | 133 | 11 | 22794259 |
| Pubmed | 2.95e-05 | 16 | 133 | 3 | 17631878 | ||
| Pubmed | 3.17e-05 | 156 | 133 | 6 | 29961565 | ||
| Pubmed | 3.41e-05 | 320 | 133 | 8 | 28685749 | ||
| Pubmed | PDE1C KRT14 KALRN SPTA1 PPFIA1 SPTAN1 MATR3 SPTBN1 NDUFA9 SPTBN4 EIF4G1 PRKCB TNKS1BP1 METAP2 DYNC1H1 VCP CACNA2D3 | 3.42e-05 | 1431 | 133 | 17 | 37142655 | |
| Pubmed | beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. | 3.57e-05 | 17 | 133 | 3 | 11371349 | |
| Pubmed | WAPL WDR36 EP400 ATRX MATR3 WDR55 ETV6 ZC3H18 TRNT1 MTA1 EIF4G1 DDX23 VCP HELLS | 3.61e-05 | 1014 | 133 | 14 | 32416067 | |
| Pubmed | Dlx3 is a crucial regulator of hair follicle differentiation and cycling. | 4.28e-05 | 18 | 133 | 3 | 18684741 | |
| Pubmed | 4.28e-05 | 18 | 133 | 3 | 20335364 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 11294830 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 26291522 | ||
| Pubmed | Megalin mediates selenoprotein P uptake by kidney proximal tubule epithelial cells. | 4.34e-05 | 3 | 133 | 2 | 18174160 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 9003415 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 24843127 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 26942602 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 18335582 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 7568196 | ||
| Interaction | SPTBN1 interactions | CYLD KALRN SPTAN1 SPTBN1 PSMD7 ZC3H18 PEX5L ITGB3 SPTBN4 STK3 NAV2 TNKS1BP1 LYN VCP | 6.46e-07 | 421 | 131 | 14 | int:SPTBN1 |
| Interaction | DOK1 interactions | 2.28e-06 | 59 | 131 | 6 | int:DOK1 | |
| Interaction | TNIK interactions | KALRN CENPF SPTAN1 MATR3 SPTBN1 PEX5L DNAJC2 AKAP9 PRKCB TAF5 LYN DYNC1H1 | 7.38e-06 | 381 | 131 | 12 | int:TNIK |
| Interaction | TNKS1BP1 interactions | 1.43e-05 | 168 | 131 | 8 | int:TNKS1BP1 | |
| Interaction | ANK1 interactions | 3.15e-05 | 56 | 131 | 5 | int:ANK1 | |
| Interaction | PDE4A interactions | 4.10e-05 | 30 | 131 | 4 | int:PDE4A | |
| Interaction | ANK2 interactions | 4.34e-05 | 98 | 131 | 6 | int:ANK2 | |
| Interaction | SMC3 interactions | WAPL ATRX MATR3 ZC3H18 MTA1 KBTBD4 AKAP9 DYNC1H1 NOTCH1 SMC1B HELLS | 7.39e-05 | 408 | 131 | 11 | int:SMC3 |
| Interaction | PDLIM5 interactions | 7.54e-05 | 273 | 131 | 9 | int:PDLIM5 | |
| Interaction | H3C1 interactions | WAPL ATRX SPTAN1 LRRK2 WDR55 DDX10 PIKFYVE MTA1 ARID2 EIF4G1 SMARCA1 NAV2 PRKCB TAF5 TARBP1 DYNC1H1 HELLS | 7.62e-05 | 901 | 131 | 17 | int:H3C1 |
| Interaction | MECP2 interactions | KRT14 ZNF354A WDR36 EP400 ATRX KALRN SPTAN1 MATR3 SPTBN1 SPOCK2 ZC3H18 ZBED5 MAMDC2 ARID2 EIF4G1 DDX23 TNKS1BP1 SEC63 METAP2 DYNC1H1 VCP | 8.39e-05 | 1287 | 131 | 21 | int:MECP2 |
| Interaction | RPS10 interactions | CYLD HIP1 ZNF354A PPFIA1 LRRK2 ZC3H18 DNAJC2 DDX10 EIF4G1 SEC63 METAP2 VCP HERC5 | 8.46e-05 | 567 | 131 | 13 | int:RPS10 |
| Interaction | KRT6A interactions | 8.54e-05 | 160 | 131 | 7 | int:KRT6A | |
| Interaction | DLK2 interactions | 8.55e-05 | 36 | 131 | 4 | int:DLK2 | |
| Interaction | SPTAN1 interactions | CYLD KALRN CENPE PPFIA1 SPTAN1 SPTBN1 PEX5L ITGB3 SPTBN4 PRKCB LYN VCP | 9.69e-05 | 496 | 131 | 12 | int:SPTAN1 |
| Interaction | HDAC6 interactions | CYLD KRT14 ZNF354A KRT17 EP400 SPTAN1 MATR3 SPTBN1 LRRK2 ETV6 NDUFA9 EIF4G1 NAV2 LYN DYNC1H1 VCP USP47 | 1.10e-04 | 929 | 131 | 17 | int:HDAC6 |
| Interaction | MYH9 interactions | CYLD HIP1 SPTAN1 SPTBN1 LRRK2 PSMD7 ZC3H18 PEX5L ITGB3 KBTBD4 EIF4G1 TNKS1BP1 LYN VCP USP47 | 1.16e-04 | 754 | 131 | 15 | int:MYH9 |
| Interaction | USP10 interactions | 1.19e-04 | 290 | 131 | 9 | int:USP10 | |
| Interaction | SUMO2 interactions | WAPL EP400 ATRX KALRN SPTAN1 SPTBN1 LRRK2 ETV6 MTA1 ARID2 EIF4G1 DYNC1H1 VCP | 1.28e-04 | 591 | 131 | 13 | int:SUMO2 |
| Interaction | DSCAM interactions | 1.29e-04 | 171 | 131 | 7 | int:DSCAM | |
| Interaction | SHC1 interactions | 1.30e-04 | 362 | 131 | 10 | int:SHC1 | |
| Interaction | SPTBN2 interactions | 1.34e-04 | 172 | 131 | 7 | int:SPTBN2 | |
| Interaction | CBL interactions | UBR2 KRT14 MAN1A1 KRT17 SPTA1 SPTAN1 SPTBN1 INSR ITGB3 LYN NOTCH1 HERC5 | 1.40e-04 | 516 | 131 | 12 | int:CBL |
| Interaction | HTT interactions | PDE1A HIP1 STAB2 SPTA1 SPTAN1 MATR3 SPTBN1 PSMD7 NDUFA9 PEX5L ITGB3 CBS PRKCB LYN DYNC1H1 VCP MGRN1 | 1.43e-04 | 949 | 131 | 17 | int:HTT |
| Interaction | NUPR1 interactions | HIP1 WDR36 SPTAN1 MATR3 SPTBN1 WDR55 ZC3H18 EIF4G1 SMARCA1 DDX23 TNKS1BP1 RNASEH1 LYN VCP | 1.46e-04 | 683 | 131 | 14 | int:NUPR1 |
| Interaction | H2AZ1 interactions | EP400 ZC3H18 TRNT1 MTA1 ARID2 SMARCA1 DDX23 PRKCB TARBP1 DYNC1H1 | 1.59e-04 | 371 | 131 | 10 | int:H2AZ1 |
| Interaction | CIT interactions | CYLD HIP1 WDR36 EP400 KALRN CENPF SPTAN1 MATR3 SPTBN1 LRRK2 ACVR1 DDX10 SPTBN4 AKAP9 NUP210 EIF4G1 SMARCA1 DDX23 TNKS1BP1 TAF5 TARBP1 DYNC1H1 | 1.60e-04 | 1450 | 131 | 22 | int:CIT |
| Interaction | SFN interactions | CYLD PPFIA1 SPTAN1 MATR3 SPTBN1 INSR LRRK2 ZC3H18 AKAP9 EIF4G1 NAV2 VCP USP47 ARAP2 | 1.67e-04 | 692 | 131 | 14 | int:SFN |
| Interaction | KRT7 interactions | 1.75e-04 | 80 | 131 | 5 | int:KRT7 | |
| Interaction | BIN3 interactions | 1.89e-04 | 44 | 131 | 4 | int:BIN3 | |
| Interaction | PRC1 interactions | WDR36 ATRX CENPE CENPF SPTAN1 MATR3 SPTBN1 PSMD7 ZC3H18 NDUFA9 SPTBN4 AKAP9 NUP210 SMARCA1 DDX23 DYNC1H1 VCP | 1.92e-04 | 973 | 131 | 17 | int:PRC1 |
| Interaction | HSPB1 interactions | CYLD KRT17 TTC39C MATR3 SPTBN1 LRRK2 ZC3H18 PTK6 EDEM3 KBTBD4 EIF4G1 PRKCB DYNC1H1 VCP | 2.12e-04 | 708 | 131 | 14 | int:HSPB1 |
| Interaction | FBXO22 interactions | CYLD WAPL CENPE CENPF PPFIA1 SPTBN1 PSMD7 ARID2 NAV2 DDX23 HYDIN HELLS | 2.13e-04 | 540 | 131 | 12 | int:FBXO22 |
| Interaction | LCK interactions | CYLD KALRN PPFIA1 SPTAN1 SPTBN1 PTK6 TNKS1BP1 PLCG2 LYN NOTCH1 ARAP2 | 2.23e-04 | 463 | 131 | 11 | int:LCK |
| GeneFamily | EF-hand domain containing|Spectrins | 2.58e-08 | 7 | 96 | 4 | 1113 | |
| GeneFamily | Ankyrin repeat domain containing | ANKRD30B KRIT1 NUDT12 FANK1 ANKRD34B ANKRD12 NOTCH1 ARAP1 ARAP2 | 5.60e-06 | 242 | 96 | 9 | 403 |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.79e-04 | 53 | 96 | 4 | 532 | |
| GeneFamily | Phosphodiesterases | 2.71e-04 | 24 | 96 | 3 | 681 | |
| GeneFamily | Keratins, type I | 4.32e-04 | 28 | 96 | 3 | 608 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 1.49e-03 | 11 | 96 | 2 | 1168 | |
| GeneFamily | Low density lipoprotein receptors | 2.09e-03 | 13 | 96 | 2 | 634 | |
| GeneFamily | Parkinson disease associated genes | 3.19e-03 | 16 | 96 | 2 | 672 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | UBR2 WAPL ATRX CENPE CENPF PPFIA1 ACVR1 DNAJC2 KRIT1 DDX10 PIKFYVE STK3 AKAP9 SMARCA1 SETD3 LYN ARAP2 | 1.66e-06 | 856 | 133 | 17 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | UBR2 WAPL ATRX CENPE CENPF PPFIA1 ACVR1 KRIT1 PIKFYVE STK3 AKAP9 LYN | 4.76e-06 | 466 | 133 | 12 | M13522 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CYLD UBR2 WAPL MAN1A1 EP400 ATRX TTC39C SPTAN1 MATR3 OAS2 SPOCK2 ZBED5 PIKFYVE AKAP9 ARID2 NUP210 PRKCB DYNC1H1 NOTCH1 USP47 ARAP2 | 2.03e-05 | 1492 | 133 | 21 | M40023 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.71e-05 | 151 | 133 | 7 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | CYLD AVEN WDR36 CENPF FBXL5 DDX10 PIKFYVE NUP210 HFM1 CEP295 ANKRD12 PLCG2 TAF5 SETD3 SMC1B HELLS | 5.58e-05 | 820 | 133 | 16 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500 | 7.07e-05 | 161 | 133 | 7 | gudmap_developingGonad_e12.5_ovary_k3_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 7.35e-05 | 162 | 133 | 7 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-09 | 184 | 133 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-09 | 184 | 133 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-09 | 184 | 133 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.85e-09 | 189 | 133 | 9 | a75226616340045b581d08429d2e123e041dee55 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.57e-09 | 200 | 133 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.64e-08 | 187 | 133 | 8 | f18628ffc7ff7c762b8339ba8822cf0c3157f469 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-07 | 189 | 133 | 8 | c3df0e3c50af8f1cfb4d790e668bd7f42b276992 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-07 | 190 | 133 | 8 | d594da827e3c16644952b9589cc12b947ce36279 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-07 | 190 | 133 | 8 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-07 | 192 | 133 | 8 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-07 | 192 | 133 | 8 | 5c7e8b80b44d9ce55c797cdf8267ac5382e26cac | |
| ToppCell | BLOOD--(1)_Activated_T_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.33e-07 | 195 | 133 | 8 | 45515d5da8a8c8242eb70a1bea24fe44eca5407b | |
| ToppCell | mild-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.44e-07 | 197 | 133 | 8 | 39800e6e83f2d333b753d121c7aeb2912b91faa2 | |
| ToppCell | Mild/Remission-B_intermediate-0|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.55e-07 | 199 | 133 | 8 | 592111591f0f6816fc56620cb555eb48dabf0758 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-Tregs|blood / Manually curated celltypes from each tissue | 1.38e-06 | 184 | 133 | 7 | 22c15ce30171c687ab564f4383ae74d38b759272 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-06 | 186 | 133 | 7 | 84ba666237c18189d7e7556bd92dd953af733c00 | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.96e-06 | 194 | 133 | 7 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.17e-06 | 197 | 133 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 2.24e-06 | 198 | 133 | 7 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | Neuronal-Excitatory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.39e-06 | 200 | 133 | 7 | 4409065bc7aa995354c71e0f9d6f3726cf393d6b | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.81e-06 | 157 | 133 | 6 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.04e-05 | 165 | 133 | 6 | dbe231d00843cae917efd1abea6079ace3b45cdf | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.04e-05 | 165 | 133 | 6 | 9ccce713d4122054bf4bef4a7126d90cf9141b84 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic-Neutrophil|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-05 | 172 | 133 | 6 | c32e6af9e2d29da47b5d870207b598cff11aef6c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-05 | 172 | 133 | 6 | 0b247fe57163af08132db8df42e6757699885295 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-05 | 172 | 133 | 6 | 1a0556c97fcba126126c22adea5235d977d41ebe | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 173 | 133 | 6 | a5172dee859bf6c2eed46c48bd64dfef0ff9f28f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 173 | 133 | 6 | 639b5b0b33ce5aa0bc26363c059717012ddc14c0 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-05 | 173 | 133 | 6 | b7e0193fd4983cb38d1bee441f608f73ee8743b9 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-05 | 174 | 133 | 6 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | Healthy_donor-Treg|World / disease group, cell group and cell class (v2) | 1.40e-05 | 174 | 133 | 6 | dc3b06420b0ad9c7060571e7bf5714e028d598bf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-05 | 175 | 133 | 6 | 9a96a946db731ba24c9be34bedebf1f4a1372b9e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-05 | 175 | 133 | 6 | 54c1f080195ad8392a095e83b56a4b54073d4c0d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 175 | 133 | 6 | 65571d775d26a40e979dbf290a8e4320c0d9fb3f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-05 | 175 | 133 | 6 | 2b51406a2c2daa13ab4ed283ede038cd11d9e641 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.54e-05 | 177 | 133 | 6 | cbedac0bddb8fc330a464815c905928c553b0fc0 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.59e-05 | 178 | 133 | 6 | 04bfecf5ea5d85c843e48d08718b5d69e7bf834e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.65e-05 | 179 | 133 | 6 | d3d3a9afaac28fa4f2c448c73d79bcbbbea088d7 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.70e-05 | 180 | 133 | 6 | 6bb9f41c3a99d1bbe697f589fb2bcea9b7bfbeee | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.81e-05 | 182 | 133 | 6 | 1aea96ee211f7b9caef7fd385233f51be6021a73 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.81e-05 | 182 | 133 | 6 | b427e43ee523a3ea9eca3207f3d82042f10f022a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.81e-05 | 182 | 133 | 6 | c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.81e-05 | 182 | 133 | 6 | 4cb182ef39be2044a6ad7266f332d4177591e550 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.86e-05 | 183 | 133 | 6 | 7717fce227b4e02ed41baad8ae7dd2e22bd7c13e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.92e-05 | 184 | 133 | 6 | 300edc4aa3ce55f309005c02c315fa0102ea9da7 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.92e-05 | 184 | 133 | 6 | 8b397f9c18ed7abecdbcbd586d0ddadf07cf6e75 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-05 | 186 | 133 | 6 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-05 | 186 | 133 | 6 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-05 | 186 | 133 | 6 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell|TCGA-Uvea / Sample_Type by Project: Shred V9 | 2.04e-05 | 186 | 133 | 6 | e8580a2093eb7e50aad55ec7fada850d2fed8ae1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-05 | 188 | 133 | 6 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.17e-05 | 188 | 133 | 6 | e5c480b9a030536578f1cc91fb61738f752525b3 | |
| ToppCell | 343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.24e-05 | 189 | 133 | 6 | c26428871dc3261327d89cacaba6e21e004ff1f3 | |
| ToppCell | COVID-19_Mild-Treg|COVID-19_Mild / Disease condition and Cell class | 2.24e-05 | 189 | 133 | 6 | f0fceb5f87ca260bfe038c0db3487a6d2e1b0a6e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 190 | 133 | 6 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)|World / shred by cell type and Timepoint | 2.30e-05 | 190 | 133 | 6 | 53f017a11ca5ebe9025558e12cedc409cab2e5aa | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 190 | 133 | 6 | 3dcadabbefe0128a5f30ab51234f049ab4d870c6 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.37e-05 | 191 | 133 | 6 | c5e22df4a8741b8096cdd1618271fd48d6265846 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.37e-05 | 191 | 133 | 6 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 2.37e-05 | 191 | 133 | 6 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 191 | 133 | 6 | 47a2afc4102199b4bc76bd01b2967c8016186462 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 2.44e-05 | 192 | 133 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | Control-Lymphoid_T/NK-Treg|Control / Disease group, lineage and cell class | 2.52e-05 | 193 | 133 | 6 | 715f2bbee12a7952cba85d9cd8820411983ce790 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.52e-05 | 193 | 133 | 6 | 194b49c152e3e3f599068ec88a7f0af6427b743a | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.52e-05 | 193 | 133 | 6 | 097a244cf37ce6c1ace9bae56beb7de59442cd6b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.59e-05 | 194 | 133 | 6 | 2faf49d85d09932c9c20d9f675c8093ad802fae5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.59e-05 | 194 | 133 | 6 | fd3d5ac94de3db7136684c86f8589631ad87e6d8 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Promonocyte-like|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.67e-05 | 195 | 133 | 6 | 37b4f635b71734c6e0bc808a739af4bbe6bb47f6 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.67e-05 | 195 | 133 | 6 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.67e-05 | 195 | 133 | 6 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | AT1|World / shred by cell class for parenchyma | 2.74e-05 | 196 | 133 | 6 | 2bc487f8a109a6961ebff111dec79c2227ea60ac | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 2.82e-05 | 197 | 133 | 6 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 2.82e-05 | 197 | 133 | 6 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.82e-05 | 197 | 133 | 6 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.82e-05 | 197 | 133 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.90e-05 | 198 | 133 | 6 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.90e-05 | 198 | 133 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.90e-05 | 198 | 133 | 6 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_Plasmablasts|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.99e-05 | 199 | 133 | 6 | 624a807fae0a080a4e6755dcb374c25b6f2d2cfe | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 2.99e-05 | 199 | 133 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.99e-05 | 199 | 133 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.99e-05 | 199 | 133 | 6 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | Control-Control-Lymphocyte-T/NK-Treg|Control / Disease, condition lineage and cell class | 2.99e-05 | 199 | 133 | 6 | 6b7eb14bf03aa05f2d4ac4f5dd1ccf41a7e47bd1 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 2.99e-05 | 199 | 133 | 6 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 2.99e-05 | 199 | 133 | 6 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 2.99e-05 | 199 | 133 | 6 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 2.99e-05 | 199 | 133 | 6 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | 21|World / Age, Tissue, Lineage and Cell class | 2.99e-05 | 199 | 133 | 6 | 8c6517243168de4134e06dbe16ca89b1c2a73179 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 3.07e-05 | 200 | 133 | 6 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.07e-05 | 200 | 133 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | COVID_vent|World / Disease condition, Lineage, Cell class and subclass | 3.07e-05 | 200 | 133 | 6 | 1d88e5cc4534073f27a7562e1c4b884bd67f09d9 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.46e-05 | 130 | 133 | 5 | d47d4ff1263815896470d854d25306eb36919e70 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.46e-05 | 130 | 133 | 5 | ad57b210c96caedadc1027b4d7a56b1bc389b137 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-7|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.52e-05 | 136 | 133 | 5 | d94f0fbeb7b80d4cf0687d1924ebf8f9dd07358c | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.72e-05 | 137 | 133 | 5 | 12caa8ed7cc9e7a0f78c14ad5efe2fc28c3ce9be | |
| ToppCell | TCGA-Thryoid|World / Sample_Type by Project: Shred V9 | 5.92e-05 | 138 | 133 | 5 | 8cbae2ec9a51712bed5b4e5f9f834ecccb6b7a47 | |
| ToppCell | AT1-AT2_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 6.34e-05 | 140 | 133 | 5 | 45d52a086ced8d58e01ac51ac4a90338e8649b16 | |
| ToppCell | Control-NK|World / Disease group and Cell class | 7.01e-05 | 143 | 133 | 5 | fe08adc9472dfd4242497d6c614d0490713261da | |
| ToppCell | E17.5-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.79e-05 | 150 | 133 | 5 | 201d5b68e71c6c003285428be96c488e6d526edf | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.07e-05 | 151 | 133 | 5 | b698ddc74565d47892c09c3f16d78038da2dd5e7 | |
| Drug | ADPribulose | 7.64e-07 | 13 | 133 | 4 | CID000197570 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.27e-06 | 182 | 133 | 9 | 3887_DN | |
| Drug | PRODAN | 1.45e-06 | 15 | 133 | 4 | CID000028127 | |
| Drug | MAPS | 1.70e-05 | 191 | 133 | 8 | CID000066161 | |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 1.90e-05 | 194 | 133 | 8 | 4662_DN | |
| Drug | ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 1.97e-05 | 195 | 133 | 8 | 1630_UP | |
| Drug | Sulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 2.12e-05 | 197 | 133 | 8 | 2814_DN | |
| Drug | Gabapentin [60142-96-3]; Up 200; 23.4uM; PC3; HT_HG-U133A | 2.20e-05 | 198 | 133 | 8 | 5875_UP | |
| Drug | Pivmecillinam hydrochloride [32887-03-9]; Up 200; 8.4uM; PC3; HT_HG-U133A | 2.36e-05 | 200 | 133 | 8 | 7312_UP | |
| Drug | dimethyl adipimidate | 2.71e-05 | 30 | 133 | 4 | CID000025738 | |
| Drug | aminomalonate | 3.11e-05 | 11 | 133 | 3 | CID000100714 | |
| Drug | ethanol | SPTA1 SPTAN1 SPTBN1 INSR COQ6 OAS2 ACVR1 ADCY3 KRIT1 DDX10 PIKFYVE SPTBN4 LDHD TRNT1 PRKCB PLCG2 | 3.12e-05 | 837 | 133 | 16 | CID000000702 |
| Disease | neurodegenerative disease (implicated_via_orthology) | 4.21e-05 | 145 | 128 | 6 | DOID:1289 (implicated_via_orthology) | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 1.11e-04 | 4 | 128 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | Cerebral ventriculomegaly | 3.87e-04 | 7 | 128 | 2 | C1531647 | |
| Disease | Hydrocephalus Ex-Vacuo | 3.87e-04 | 7 | 128 | 2 | C0270720 | |
| Disease | Communicating Hydrocephalus | 3.87e-04 | 7 | 128 | 2 | C0009451 | |
| Disease | Fetal Cerebral Ventriculomegaly | 3.87e-04 | 7 | 128 | 2 | C2936718 | |
| Disease | Post-Traumatic Hydrocephalus | 3.87e-04 | 7 | 128 | 2 | C0477432 | |
| Disease | Obstructive Hydrocephalus | 3.87e-04 | 7 | 128 | 2 | C0549423 | |
| Disease | non-alcoholic fatty liver disease (implicated_via_orthology) | 5.13e-04 | 36 | 128 | 3 | DOID:0080208 (implicated_via_orthology) | |
| Disease | Congenital Hydrocephalus | 5.14e-04 | 8 | 128 | 2 | C0020256 | |
| Disease | Aqueductal Stenosis | 5.14e-04 | 8 | 128 | 2 | C2936786 | |
| Disease | Parkinson Disease | 5.21e-04 | 85 | 128 | 4 | C0030567 | |
| Disease | Hydrocephalus | 6.59e-04 | 9 | 128 | 2 | C0020255 | |
| Disease | factor VIII measurement | 7.01e-04 | 40 | 128 | 3 | EFO_0004630 | |
| Disease | theophylline measurement | 8.21e-04 | 10 | 128 | 2 | EFO_0021180 | |
| Disease | childhood gender nonconformity | 8.67e-04 | 43 | 128 | 3 | EFO_0020103 | |
| Disease | Drug-induced depressive state | 1.20e-03 | 12 | 128 | 2 | C0338715 | |
| Disease | dementia (is_implicated_in) | 1.20e-03 | 12 | 128 | 2 | DOID:1307 (is_implicated_in) | |
| Disease | Coffin-Siris syndrome | 1.41e-03 | 13 | 128 | 2 | C0265338 | |
| Disease | – | 1.41e-03 | 13 | 128 | 2 | 608446 | |
| Disease | Connective Tissue Diseases | 1.41e-03 | 13 | 128 | 2 | C0009782 | |
| Disease | Myocardial infarction, susceptibility to | 1.41e-03 | 13 | 128 | 2 | cv:C1832662 | |
| Disease | lymphocyte measurement | 1.72e-03 | 117 | 128 | 4 | EFO_0803546 | |
| Disease | Down syndrome (implicated_via_orthology) | 1.89e-03 | 15 | 128 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | Proteinuria | 1.89e-03 | 15 | 128 | 2 | HP_0000093 | |
| Disease | eosinophil count | UBR2 WDR36 SPTBN1 ZNF429 OAS2 ACVR1 ITGB3 NAA25 AKAP9 PDE8B PRKCB HFM1 TNKS1BP1 RNASEH1 NOTCH1 | 2.03e-03 | 1488 | 128 | 15 | EFO_0004842 |
| Disease | obsolete_red blood cell distribution width | EP400 KALRN SPTA1 KHNYN INSR FANK1 NUP210 HFM1 ANKRD12 LYN QSOX2 NOTCH1 USP47 HELLS | 2.17e-03 | 1347 | 128 | 14 | EFO_0005192 |
| Disease | cyclic adenosine monophosphate measurement | 2.43e-03 | 17 | 128 | 2 | EFO_0010473 | |
| Disease | lifestyle measurement, anxiety disorder measurement | 3.04e-03 | 137 | 128 | 4 | EFO_0007795, EFO_0010724 | |
| Disease | Chronic myeloproliferative disorder | 3.04e-03 | 19 | 128 | 2 | C1292778 | |
| Disease | ulcerative colitis | 3.49e-03 | 335 | 128 | 6 | EFO_0000729 | |
| Disease | inflammatory bowel disease | 3.52e-03 | 449 | 128 | 7 | EFO_0003767 | |
| Disease | Colorectal Carcinoma | 3.60e-03 | 702 | 128 | 9 | C0009402 | |
| Disease | HIV-1 infection, Susceptibility to viral and mycobacterial infections | 3.71e-03 | 21 | 128 | 2 | EFO_0000180, Orphanet_391311 | |
| Disease | Seckel syndrome | 4.07e-03 | 22 | 128 | 2 | C0265202 | |
| Disease | seminoma (is_marker_for) | 4.07e-03 | 22 | 128 | 2 | DOID:4440 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ERDFWKEADLSMFDL | 1401 | Q96L91 | |
| RLQFETADDEDFIWV | 3536 | Q99996 | |
| TRLFLDGEEEKEWAF | 216 | Q9NRN7 | |
| VDDRWEEQRAKFQSF | 411 | Q9P2K9 | |
| FLADDFDVKEWINAA | 6 | P83436 | |
| KDDEENSWDFESFLE | 721 | Q9BXX2 | |
| VLWVDDDFLFNEETK | 396 | Q8NHY0 | |
| DKEFDDLEERFQWVS | 266 | A1IGU5 | |
| IFSSRDEKSWFRETE | 236 | Q04771 | |
| RDFVKFWKDIVDDNE | 231 | Q68CP9 | |
| ADDWFSDDSLVKRNS | 151 | Q5T7R7 | |
| EEKFVDAVNSAFWSD | 286 | Q9Y2Z9 | |
| DDDDFETNWIVDRNL | 301 | O76090 | |
| TFVFRVEKEEERNDW | 551 | Q8WZ64 | |
| QRSVEFDREFWKENF | 686 | Q6UB98 | |
| WKENFFKSDETEDLF | 696 | Q6UB98 | |
| FDSWREFSYLDEEEK | 221 | Q99543 | |
| SDAAWEDKDEFLDVI | 31 | Q9BUV8 | |
| EENSEIVVWREFDKS | 306 | Q6ZRP7 | |
| FWRKEDSDAIDWNEA | 106 | P47874 | |
| DSDAIDWNEADALEF | 111 | P47874 | |
| FEDESFDRLLWSAKE | 106 | Q7Z304 | |
| VTVSSEEFEDKWFRK | 346 | Q96K31 | |
| FKDLELAGSNDDTWD | 211 | A5PLL1 | |
| ESGFQDKEELTWEDF | 906 | Q9NRD9 | |
| VFEWTIVKDSEADRF | 156 | Q8TEM1 | |
| DSRYENFIRWEDKES | 351 | P41212 | |
| DDLKSFESWFDITSL | 406 | Q9NRZ9 | |
| LSETDEKFWAFSFDE | 131 | Q5VXI9 | |
| NEWGDEDLETKKFRF | 1811 | P46531 | |
| WLAENDRFEEAQKAF | 871 | Q9HBG6 | |
| DDWEEKRHFRRDSFD | 176 | P43243 | |
| ASEEIWNDFREAAEA | 161 | P50579 | |
| DAEYWNSQKDFLEDR | 86 | Q30154 | |
| IDRLFFSFVEEWSES | 286 | Q9GZQ4 | |
| DAEEWFFTKTEELNR | 301 | P02533 | |
| FKIDFSEWKDDELNF | 176 | O60291 | |
| SEWKDDELNFDLDRG | 181 | O60291 | |
| DSILADWNEDIEAFE | 911 | Q9BZQ6 | |
| WDAFATEFFEDDATL | 51 | O43679 | |
| QEHLKRFETSFEEWS | 111 | Q5BJE1 | |
| DVDKWSFDVFALNEA | 156 | P54750 | |
| EALKDVDKWSFDVFS | 161 | Q14123 | |
| RWKDSDRDDFLDDFG | 221 | Q76G19 | |
| FERAKAAVESDTEFW | 266 | Q8IYB4 | |
| LDNEESWDFNIFELE | 551 | O95263 | |
| LDQEWKSFAAALDER | 396 | O60229 | |
| FDEDDDKSFRRAPSW | 1126 | Q13136 | |
| DGNFSEDVLSKFDEW | 861 | Q5S007 | |
| EDVLSKFDEWTFIPD | 866 | Q5S007 | |
| SSVTEDKERQWVDDF | 276 | O00522 | |
| RDVEAWFFSKTEELN | 291 | P19012 | |
| PEWNETFRFQLKESD | 221 | P05771 | |
| NDRIYWSDFKEDVIE | 4241 | P98164 | |
| LVFWERQAEDSELFE | 656 | P06213 | |
| SRENSIWDEKYDAVD | 296 | P16885 | |
| VEFATDRVEELFEWF | 886 | P16885 | |
| KFVFEWDASEDTSID | 271 | Q9BUQ8 | |
| AFWREKEEELEVSFE | 441 | P29728 | |
| GRDWETKNFDFEDVF | 131 | Q16795 | |
| LWDFKSRTDEELSFR | 16 | Q13882 | |
| FENEDLRKELWVSFS | 701 | Q9UII4 | |
| WDDFDDENLEVTSFS | 1271 | A2PYH4 | |
| SFASEEFWKGRVEQE | 386 | Q96MT3 | |
| WFKDIKFDDSDTEQI | 466 | Q9Y2I7 | |
| FEDKTDLFQDVKWSD | 136 | Q96EW2 | |
| LTEEERKAAWAEYEA | 2266 | P46100 | |
| SLEWEERETFQKFSV | 451 | Q8N6C5 | |
| FLWKVFATQQEEDRE | 331 | Q4G0P3 | |
| AEDWFFSKTEELNRE | 271 | Q04695 | |
| KFDVDDFAESWRVES | 516 | Q8N8U9 | |
| REFDDILQWDFTEDF | 176 | Q9C0J1 | |
| DSWKERFLDVENELS | 1891 | P49454 | |
| SFSQFRFAEEKEWDS | 151 | Q9NQS1 | |
| WSESLNKVFVDNFDR | 191 | Q8IZS8 | |
| EEWKDVFISSSERSF | 1426 | Q8TD84 | |
| ASDFSWAKEAEERSR | 351 | Q86WU2 | |
| FDSEDKEILSWDIND | 6 | Q9NP62 | |
| DKWFKSNDEEAFTFA | 321 | P35520 | |
| FASSNKEDKSERERW | 996 | O60266 | |
| DWSKNFEVVFQDEEA | 486 | O15033 | |
| SVTAFFKWLREAEEE | 1581 | Q04637 | |
| TEEWFFKDITRKDAE | 126 | P07948 | |
| EFEEAKSWVEENLDF | 256 | P33908 | |
| FEEERARAKWDTANN | 756 | P05106 | |
| FEEDALSWEDKLNRI | 1516 | Q14204 | |
| SNDQFRDLAEESEKW | 541 | O15037 | |
| DDEWVKNRKDESRAF | 271 | Q9UKA1 | |
| QAKAKDEEEAFLDWS | 766 | Q13206 | |
| DDSAWLFFDSMADRD | 881 | Q9NQC7 | |
| MKEDWQRELEFAFED | 296 | Q9C0D2 | |
| RGRWVKDENVEFDSD | 206 | Q9BWG6 | |
| EFEERSATISKEWEQ | 2316 | Q02224 | |
| VFEDKVFWTDLENEA | 636 | Q14114 | |
| QEQWFRFSIEEEDPK | 41 | Q8TC84 | |
| RLWDAIKAFEDLETD | 736 | Q15542 | |
| AEVEFTTDWQKDAER | 136 | Q96Q11 | |
| VFNSADDFDSWFDTK | 361 | P28370 | |
| VPFDEDDKDDSVWFL | 56 | P51665 | |
| AWINFNKEEREAFAE | 211 | Q9NVX7 | |
| WAAEFAELEKERDSL | 566 | O00291 | |
| FEEESWEKSSVDNFV | 1631 | Q8IVL1 | |
| DNEVKLWTFLEDRAS | 421 | Q86TU7 | |
| VDKNEIEDARWFTRE | 411 | Q9BQG2 | |
| EEWSASEANLFEEAL | 286 | Q13330 | |
| SDTNAKRFRVLWDEE | 86 | Q96J65 | |
| AFEKSAATWDERFSA | 2061 | Q01082 | |
| TFAFRAESDVERKEW | 396 | Q96P48 | |
| FATEDEAWAFVRKSA | 61 | O60930 | |
| FRKPELWSDDFTDFV | 241 | Q13188 | |
| DEAWKVFFDDASQEI | 1391 | Q8NB66 | |
| WFGESEANVREIFDK | 551 | P55072 | |
| ADLDAAWRSFEKQIE | 341 | Q8NDV3 | |
| FSRDVDEIEAWISEK | 1556 | Q13813 | |
| RSKRDEFWDTAPAFE | 51 | Q8WUN7 | |
| SQEADVQDWEFRKRD | 836 | Q9C0C2 | |
| EFRNALYKWEFEESE | 211 | Q96K76 | |
| FRDVTIEFSLEEWEF | 6 | O95780 | |
| LFEWDNDFEDIRSED | 236 | Q7Z5K2 | |
| ALTDEESRKNWEEFG | 151 | Q9UGP8 | |
| EAFRKAAAAWEERFS | 2091 | Q9H254 | |
| LSAAFDEEARVKDWD | 1636 | Q8WWQ8 | |
| EIFVDEDKTIAFWQE | 81 | Q9BZD6 | |
| FQFFQDLDDEESWIE | 1716 | P02549 | |
| EDDKKAFIEDFWLTA | 136 | Q9Y4R7 | |
| AAAFDEWELTAAKAD | 1181 | Q8N398 | |
| KLEFWASSVEEENFD | 511 | Q49AG3 | |
| KTWSTDDFFAGLREE | 351 | Q9H6Y2 | |
| FAEDFWPEQDIKDSF | 81 | Q86V71 | |
| EDEWITIDKFTRFTD | 1371 | Q13395 | |
| FEDVAVLFTRDEWRK | 16 | O60765 | |
| DAFDSFERLKNESRW | 371 | Q8N584 | |
| EWSDELRQKFLEGFD | 491 | Q8IWV8 | |
| AFLDFKDLLESEDWE | 41 | Q8NA77 | |
| FRDEVEDDYIKSWED | 61 | Q92563 | |
| FDKENEVFRDWNSRI | 341 | Q86VM9 | |
| KFAAEEARESDWDGI | 446 | Q8NI36 | |
| FFSWDPKDRDVSEEH | 661 | Q14CX7 |